Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
Report of the Quality Standards Subcommittee of the American Academy of Neurology
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: To define and investigate key issues in the management of dementia and to make literature-based treatment recommendations.
Methods: The authors searched the literature for four clinical questions: 1) Does pharmacotherapy for cognitive symptoms improve outcomes in patients with dementia? 2) Does pharmacotherapy for noncognitive symptoms improve outcomes in patients with dementia? 3) Do educational interventions improve outcomes in patients and/or caregivers? 4) Do other nonpharmacologic interventions improve outcomes in patients and/or caregivers?
Results: Cholinesterase inhibitors benefit patients with AD (Standard), although the average benefit appears small; vitamin E likely delays the time to clinical worsening (Guideline); selegiline, other antioxidants, anti-inflammatories, and estrogen require further study. Antipsychotics are effective for agitation or psychosis in patients with dementia where environmental manipulation fails (Standard), and antidepressants are effective in depressed patients with dementia (Guideline). Educational programs should be offered to family caregivers to improve caregiver satisfaction and to delay the time to nursing home placement (Guideline). Staff of long-term care facilities should also be educated about AD to minimize the unnecessary use of antipsychotic medications (Guideline). Behavior modification, scheduled toileting, and prompted voiding reduce urinary incontinence (Standard). Functional independence can be increased by graded assistance, skills practice, and positive reinforcement (Guideline).
This guideline is retired. The recommendations and conclusions are no longer considered valid and no longer supported by the AAN. Retired guidelines should be used for historical reference only. Please see AAN current guidelines here: https://www.aan.com/policy-and-guidelines/guidelines/.
- Received July 10, 2000.
- Accepted in final form February 9, 2001.
Letters: Rapid online correspondence
- Reply to Barry S Oken
- Rachelle S Doody, Baylor College of Medicine Houston TXsandi_moriarity@urmc.rochester.edu
Submitted August 20, 2001
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Related Articles
Alert Me
Recommended articles
-
Articles
Neuropsychiatric and behavioral alterations and their management in moderate to severe Alzheimer diseaseJeffrey L. Cummings et al.Neurology, September 26, 2005 -
Review
PimavanserinA novel therapeutic option for Parkinson disease psychosisTrevor Hawkins, Brian D. Berman et al.Neurology: Clinical Practice, March 24, 2017 -
Articles
Quetiapine for agitation or psychosis in patients with dementia and parkinsonismRoger Kurlan, Jeffrey Cummings, Rema Raman et al.Neurology, April 23, 2007 -
Articles
Dementia caregiver burdenA review of the literature and guidelines for assessment and interventionJennifer J. Dunkin, Cay Anderson-Hanley et al.Neurology, July 01, 1998